Conference abstractPublished 30 Jul 2017
Fe3-δO4 nanoparticles inspired clinical therapeutics in cancer and Clostridium difficile infection
National Cheng Kung University, Taiwan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Clostridium difficile infection (CDI) and cancer both are important causes of global healthcare cahllenges. Resistance of CD spores as well as cancer cells to various therapeutic measures post a significant threat. Nanomaterials have been explored for applications in anti-microbials as well as cancer therapy with intrinsic advantages of low drug-resistance issues and high efficacy. We discovered the 22 nm octahedral Fe3-δO4 single crystal nanoparticles with a strong saturation magnetization (94 emu/g) and exhibited inhibitory effect to CD spore germination in vitro and in vivo while at the same time serve as an excellent convertor for RF induced nano-heater for cancer hyperthermia therapy. The nanocrystal presented excellent MRI contrast effect and showed a dose dependent inhibition of CD spores germination (62% growth inhibition at 500 μg/mL) close to that of sodium hypochlorite. CDI animal model established in NF-κB-reporter mice presented significant bowel inflammation in the MOCK compared to Fe3-δO4 nanoparticles treated group as revealed by in vivo imaging system. Pro-inflammatory cytokines including IL-1β, TNF-α, and INF-γ and inflammatory cell infiltrations were significantly suppressed after nanoparticle treatment. In addition, the Fe3-δO4 nanoparticles (500 μg/mL) did not alter the microbiota and induce the liver or kidney damage in vivo. On the other hand, we observed significant anti-cancer efficacy upon integration of RF-hypertehrmia with synchronized thermal responsive chemotherapy in both in vitro and in vivo with complete tumor remission achieved with targeting add-on. These results provide nano-material based strategy for infection and cancer therapeutics that encourage further clinical translational development.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNanotechnology
- SubjectInfectious Diseases
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Dar-Bin Shieh”